ZEPHYRTEL
2.4.2019 11:51:04 CEST | Business Wire | Press release
ZephyrTel, a division of ESW Capital dedicated to serving global telecommunications operators, is pleased to announce that it has today signed a telecom-focused Strategic Collaboration Agreement with Amazon Web Services (AWS).
This agreement comes less than a year after ZephyrTel’s formation and is testament to the company’s growth strategy and focus on cloud leadership in the Telco market. The strategic collaboration agreement will initially be focused on a joint go-to market approach based on ZephyrTel’s industry leading Customer Experience Management platform, ResponseTek for Telco, which was the first ZephyrTel solution to be migrated to AWS.
Work is already underway to migrate other ZephyrTel solutions to AWS, including Mobilogy, OASIS Cloud Contact Centre, Volt Delta 360 Directory Assistance, PeerApp and Vasona, as well as NewNet Messaging and the Invigorate Rating and Charging platform which ZephyrTel acquired in December 2018.
ZephyrTel’s Dev Factory is also working with AWS in the Artificial Intelligence (AI) and Machine Learning (ML) space and development is underway on the first suite of predictive analytics applications built on AWS.
Mike Shinya, CEO of ZephyrTel, said, “We are dedicated to partnering with our 330 global Telco Operator customers on their journey to becoming Digital Telcos. We expect our cloud offerings to deliver Total Cost of Ownership savings to our customers of up to 90% and we are thrilled to work with AWS’s dedicated Telecom business to extend our joint offerings.”
“Telecommunication service providers are accelerating their migration to AWS in order to deliver lower total cost of IT for their organizations as well as increase automation of their services and business processes in order to drive agility and innovation for their customers,” said Jean-Philippe Poirault, Vice President and Global Head of Telecom, Amazon Web Services EMEA SARL. “We are excited to support ZephyrTel in delivering cloud-deployable telecom solutions on AWS to enable and accelerate the digital transformation journey of our shared customers.”
The agreement will also see ZephyrTel join the AWS Partner Network (APN) with immediate effect. The APN is a global partner program that helps APN Partners build successful AWS-based businesses or solutions by providing business, technical, marketing, and go-to-market support.
About ZephyrTel
Launched in early 2018, ZephyrTel has rapidly scaled up to reach $70M revenues in a short space of time. ZephyrTel has installations in over 50 countries around the world and its customers include more than 330 of the global leading Telecom Operators. The company has access to over 4000 of the world’s top talented engineers and other skilled professionals, available through affiliated company Crossover for Work’s platform. ZephyrTel is currently serving the telecommunications industry worldwide with software products for retail, infrastructure, mobile, cloud, and customer experience and is continuously extending its telco product range. More information is available at www.zephyrtel.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190402005511/en/
Contact:
ZephyrTel For further information please email: Mike Shinya, CEO mike.shinya@zephyrtel.com Ali Perkins, Chief Marketing Officer ali.perkins@zephyrtel.com
For media enquiries please email: Paula Elliott, Managing Director, C8 Consulting paula@c8consulting.co.uk
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LPs Expect Private Markets Managers to Level Up in 2027: SS&C Intralinks Survey5.11.2026 15:00:00 CET | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the publication of the 2027 LP Survey. In association with Reuters Insights, SS&C Intralinks surveyed 400 professionals working in private markets, including 370 limited partners and allocators, to understand how the alternative investments market will change in the next 12 months.* “Alternatives once again delivered in 2026, and LPs are still committing capital, but their expectations of managers continue to rise,” said Ken Bisconti, general manager of SS&C Intralinks. “Technology and data capabilities now rank among the most important criteria for selecting managers, alongside investment strategy. Performance alone is no longer enough. For nearly one-third of allocators, a credible artificial intelligence (AI) strategy is now a prerequisite for allocating capital to a manager.” Key findings from the report include: Alternatives portfolios continue to outperform. 62% of respondents said their portfolios exceeded expectati
European Commission expands license for Alfasigma’s Jyseleca® (filgotinib) with approval of new indication, treatment of adults with axial spondylarthritis5.11.2026 15:00:00 CET | Press release
Jyseleca® (filgotinib) has received expanded approval for the treatment of patients with active axial spondylarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have not responded adequately to conventional therapy. EC approval follows a positive opinion from the CHMP in September 2026 and offers a new treatment option for people living with inadequately controlled axSpA in Europe. An application has been submitted to the MHRA for UK approval and is under review. In the OLINGUITO Phase 3 study, improvements in the signs and symptoms of axSpA – including spinal pain – were observed early and maintained over 52 weeks of treatment with filgotinib. This new indication builds on previous approvals for Jyseleca® for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis in Europe and the United Kingdom. The information contained within this press release is for the purpose of scientific exchange. It is intended for scientific, financia
Shonan Beauty Clinic Named to Newsweek’s “World’s Best Hospitals & Clinics for Medical Tourism 2027”5.11.2026 15:00:00 CET | Press release
Recognized in two Plastic & Reconstructive Surgery categories, liposuction and breast augmentation, among leading medical institutions across 13 countries SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced that Shonan Beauty Clinic, one of the clinic brands it supports, has been named to “World’s Best Hospitals & Clinics for Medical Tourism 2027,” an international ranking presented by Newsweek in partnership with Statista. The clinic was recognized in the Plastic & Reconstructive Surgery field, in both the liposuction and breast augmentation categories. The ranking covers six specialty fields across 13 countries. Within Plastic & Reconstructive Surgery, which comprises breast augmentation, liposuction, and rhinoplasty, each of the three categories names the top 75 institutions, and Shonan Beauty Clinic was recognized in two. T
Mohammed Bin Rashid Library to host third Dubai International Library and Publishing Summit under the theme “Architecture of Trust: AI and the Future of Knowledge Institutions”5.11.2026 14:43:00 CET | Press release
Mohammed Bin Rashid Library has announced the third edition of the Dubai International Library and Publishing Summit, taking place on 16 and 17 November 2026 under the theme “The Architecture of Trust: AI and the Future of Knowledge Institutions”. The Summit will bring together experts from libraries, museums, publishing houses, universities, research centres, cultural institutions and the technology sector worldwide to explore the future of knowledge institutions in the age of artificial intelligence. This year’s edition will feature more than 50 speakers representing over 40 organisations, across more than 20 panel discussions, keynote addresses and specialist workshops. The Summit will bring together local and international institutions, including leading UAE-based entities such as Zayed National Museum, the Technology Innovation Institute (TII) and Natural History Museum in Abu Dhabi, alongside international institutions such as the Leverhulme Centre for the Future of Intelligence
Current Chemicals Expands U.S. Production of Rare-Earth Fluorides With New Investment From Momentum Global Ventures5.11.2026 14:14:00 CET | Press release
Current Chemicals receives additional capital to scale U.S. capacity for critical rare-earth fluorides used in magnets, advanced coatings, and alloys Current Chemicals, Inc. (“CCI”), one of the few U.S. companies converting separated rare-earth oxides into the fluorides used to make rare-earth metals and magnets, today announced an additional investment from its lead shareholder, Momentum Global Ventures (“MGV”). The investment will significantly increase CCI’s production of neodymium fluoride, dysprosium fluoride, and other key rare-earth fluorides in Cleveland. The funding adds infrastructure, equipment and engineering staff for fluorides of neodymium, dysprosium, terbium, gadolinium, yttrium, scandium, lanthanum, and lithium for reducing light rare-earths to metal: key inputs for permanent magnets, advanced coatings, and alloys. Neodymium fluoride and dysprosium fluoride are key feedstocks for the metal at the core of high-performance magnets in electric motors, wind turbines and de
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom